Several studies showed that IFITM1 critically regulates epidermal growth factor receptor-mediated signaling in non-small cell lung cancer models and is associated with a poor prognosis of patients with adenocarcinoma (49–51). This evidence concerns the gene IFITM1 and non-small cell lung carcinoma.